Erratum to

Van den Bosch, Filip; Ostor, Andrew J.K.; Wassenberg, Siegfried; Chen, Naijun; Wang, Chen; Garg, Vishvas; Kalabic, Jasmina

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Erratum to

Date

2017

Authors

Van den Bosch, Filip

Ostor, Andrew J.K.

Wassenberg, Siegfried

Abstract

In the original publication, ADA treatment values mentioned in the results section, under the heading ‘Study Outcomes’ were published incorrectly. The correct text should read ‘‘Additionally, compared to PSP users, PSP non-users had significantly lower percentage of patients that started at PAM-13 level 4 at baseline and remained at level 4 until week 78 of ADA treatment (52.4% vs 28.9%, p = 0.001)’’.

URI

https://dspace-test.anu.edu.au/handle/1885/733745393

Collections

DevOps Pure Testing

Source

Rheumatology and Therapy

Type

Comment/debate

DOI

10.1007/s40744-017-0065-3

Full item page

Cultural advice

Erratum to

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

Collections

Source

Type

Book Title

Entity type

Access Statement

License Rights

DOI

Restricted until